Drug recall · November 1, 2017
AndroGel recall
Why: Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
AndroGel (testosterone gel) 1.62%, 40.5mg in 2.5g aluminum foil packet, 30 Packets per carton. Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064 USA. NDC: 0051-8462-30
- Lots / codes
Lot: D60010A, EXP. 01/2019
- Quantity
- 48 cartons (30 foil packets per carton)
- Company
- AbbVie Inc., North Chicago, IL
- Distribution
- AZ
- Initiated
- September 8, 2017 · Voluntary: Firm initiated
- Classified
- October 25, 2017
- Reported
- November 1, 2017
- Ended
- April 23, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Testosterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.